Compare CRBU & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | RGP |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.6M | 138.0M |
| IPO Year | 2021 | 2000 |
| Metric | CRBU | RGP |
|---|---|---|
| Price | $1.68 | $4.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $10.75 | $7.00 |
| AVG Volume (30 Days) | ★ 1.8M | 450.3K |
| Earning Date | 05-08-2026 | 04-08-2026 |
| Dividend Yield | N/A | ★ 6.85% |
| EPS Growth | ★ 3.64 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $551,331,000.00 |
| Revenue This Year | $1.63 | N/A |
| Revenue Next Year | $10.93 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.22 | $3.06 |
| 52 Week High | $3.53 | $6.07 |
| Indicator | CRBU | RGP |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 40.39 |
| Support Level | $1.39 | $3.47 |
| Resistance Level | $1.73 | $4.81 |
| Average True Range (ATR) | 0.13 | 0.23 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 28.05 | 21.16 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.